EP2914343
COMBINATION OF ANTI-CD20 ANTIBODY AND PI3 KINASE SELECTIVE INHIBITOR
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
1.11.2013EP published:
6.3.2019EP application number:
13792152.4
EPO information:
European Patent Register
Max expiry date:
31.10.2033
Title:
COMBINATION OF ANTI-CD20 ANTIBODY AND PI3 KINASE SELECTIVE INHIBITOR
Timeline
Today
1.11.2013EP application
6.3.2019EP Publication
Owner
Name:
TG Therapeutics, Inc.Address:
2 Gansevoort St., 9th Floor, 10014, New York, NY, US
Name:
Rhizen Pharmaceuticals S.A.Address:
Fritz Courvoisier 40, 2300, La Chaux de Fonds, CH
Name:
Laboratoire Français du Fractionnement et des BiotechnologiesAddress:
3, Avenue des Tropiques ZA de Courtaboeuf, 91940, Les Ulis, FR
Inventor
Name:
WEISS, MichaelAddress:
New York, NY, US
Name:
MISKIN, HariAddress:
New YorkNew York, US
Name:
SPORTELLI, PeterAddress:
New YorkNew York, US
Name:
VAKKALANKA, Swaroop K.V.S.Address:
La Chaux de Fonds, CH
Priority
Number:
CH45952012Date:
2.11.2012Country:
IN
Number:
201361771812 PDate:
2.3.2013Country:
US
Classification
Categories:
A61P 35/00, A61K 39/395, A61K 45/06, A61K 31/519, A61P 37/00